HL7 International is pleased to announce the appointment of three distinguished members to its 2025 Board of Directors.
These new appointees bring a wealth of industry leadership and expertise across data standards, artificial intelligence and clinical innovation, and will serve a two-year term:
- Christopher Longhurst, M.D., M.S., FACMI, chief clinical and innovation officer, University of California, San Diego (UCSD)
Longhurst is a nationally recognized leader in clinical informatics and digital health innovation. As the chief clinical and innovation officer at UCSD, Dr. Longhurst oversees a broad portfolio, including the Offices of the Chief Medical Officer, Quality and Patient Safety, Care Management, Information Services, and the Jacobs Center for Health Innovation, where he leads AI initiatives for personalized medicine and health equity. His leadership in developing cutting-edge health IT aligns with HL7’s mission to empower global health interoperability. - Genevieve Melton-Meaux, M.D., Ph.D., FACMI, director, Center for Learning Health System Sciences, University of Minnesota
Melton-Meaux is an accomplished leader in clinical informatics and AI implementation. With extensive research on learning health systems and digital transformation, she has pioneered strategies that optimize health IT and promote evidence-based care. The current chair of the American Medical Informatics Association (AMIA), her global recognition in AI-driven healthcare innovation underscores HL7’s dedication to advancing intelligent, interoperable solutions.
After 32 years of serving HL7 International as the Executive Director, Mark McDougall will retire at the end of this year. HL7 leadership would like to acknowledge Mark's significant contributions to the organization across the decades.
Andy Truscott, FHL7, HL7 Board Chair states, "Mark's unwavering commitment and visionary leadership have been pivotal in advancing healthcare standards and interoperability across our organization. As Executive Director, Mark consistently demonstrated an extraordinary dedication to our mission. His ability to navigate the ever-evolving landscape of healthcare informatics and standards development has been instrumental in shaping HL7 into the dynamic organization it is today. Mark's passion for improving healthcare outcomes through enhanced interoperability has not only guided our work but has served as an inspiration to us all.
As Mark prepares to embark upon retirement, we wish him all the best in his future endeavors. His legacy within HL7 will be enduring, shaping the way we approach healthcare standards and data exchange for years to come.
We acknowledge and honor his exemplary service and commitment to our cause. Thank you, Mark, for your invaluable contributions, and we wish you a retirement filled with happiness, health and new adventures."
HL7® International, the global authority on interoperability of health information technology with members in 55 countries, today announced the appointment of two new members to the HL7 board of directors to serve a two-year term: Aashima Gupta, director, global healthcare solutions, Google Cloud; Judy Wawira Gichoya, M.D., M.S., assistant professor, radiology and imaging sciences, Emory University School of Medicine.
“These leaders represent a critical cross section of global stakeholders who are committed to advancing health through information technology. We are delighted to welcome them to the HL7 board of directors,” said Charles Jaffe, M.D., Ph.D., CEO of HL7. “Their strategic expertise and diverse experience will contribute greatly to HL7’s goal of improving the quality of care and reducing costs by overcoming the barriers to interoperability.”
Health Level Seven® (HL7®) International recently announced the appointment of three new members to the HL7 board of directors to serve a two-year term: Lori Evans Bernstein, MPH, co-founder and president, HealthReveal; Karen DeSalvo, M.D., MPH, chief health officer, Google Health; and Carolyn Petersen, MS, MBI, FAMIA, senior editor, Mayo Clinic.
“These leaders represent a broad spectrum of global stakeholders who are committed to advancing health through information technology. We are delighted to welcome them to the HL7 board of directors,” said Charles Jaffe, M.D., Ph.D., CEO of HL7. “Their strategic expertise and diverse experience will contribute greatly to HL7’s goal of improving the quality of care and reducing costs by overcoming the barriers to interoperability.”